Shares of HIMS experienced a dramatic drop today following the unexpected cancellation of its agreement with pharmaceutical giant Novo Nordisk. Investors responded negatively to the news, sending the company's stock price plummeting by nearly fifteen percent. The reason for the dissolution of the partnership remains unclear, but industry analysts s